Ralf Kuriyel — Senior Vice President of Research & Development at Repligen Corporation

Mr. Ralf Kuriyel has been Senior Vice President of Research and Development at Repligen Corporation since October 2016. Mr. Kuriyel served as Vice President of Applications for the single-use business unit within the Life Sciences division of Pall Corporation, whose acquisition by Danaher Corporation was completed in August 2015. During his 11-year tenure at Pall, Mr. Kuriyel played a key role in expanding the Global Applications R&D function to include cell culture and single-use applications, process monitoring technologies and process development services. Prior to Pall, he held various technology and applications development management roles within the Biopharmaceutical Division of Millipore Corporation, which was acquired by Merck KGaA in 2010. He is an inventor of multiple patents and has co-authored over 30 scientific publications pertaining to bioprocessing, including separations technologies, membrane separations methods, protein processing and enhanced microfiltration techniques. Mr. Kuriyel received his B.S. and M.S. in Chemical Engineering from Rensselaer Polytechnic Institute and completed coursework for the Tufts University Ph.D. program in Chemical Engineering.